Skip to Content

Lazard US Equity Concentrated R6 RLUEX

Medalist Rating as of | See Lazard Investment Hub
  • NAV / 1-Day Return 8.62  /  −0.12 %
  • Total Assets 140.9 Mil
  • Adj. Expense Ratio
    0.780%
  • Expense Ratio 0.780%
  • Distribution Fee Level High
  • Share Class Type Retirement, Large
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 1.10%
  • Turnover 81%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:23 PM GMT+0

Morningstar’s Analysis RLUEX

Will RLUEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Shaking things up.

Analyst David Carey

David Carey

Analyst

Summary

Changes at Lazard US Equity Concentrated warrant caution.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RLUEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 62.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Laboratory Corp of America Holdings

11.31 16.2 Mil
Healthcare

Alphabet Inc Class A

8.06 11.5 Mil
Communication Services

S&P Global Inc

6.83 9.8 Mil
Financial Services

Oracle Corp

6.21 8.9 Mil
Technology

Analog Devices Inc

5.46 7.8 Mil
Technology

Fidelity National Information Services Inc

5.26 7.5 Mil
Technology

Visa Inc Class A

4.98 7.1 Mil
Financial Services

Otis Worldwide Corp Ordinary Shares

4.93 7.0 Mil
Industrials

Public Storage

4.83 6.9 Mil
Real Estate

Crown Castle Inc

4.74 6.8 Mil
Real Estate